Logo image of LION

LIONSGATE STUDIOS CORP (LION) Stock Fundamental Analysis

NASDAQ:LION - Nasdaq - CA53626M1041 - Common Stock - Currency: USD

8.31  -0.32 (-3.71%)

After market: 8.31 0 (0%)

Fundamental Rating

2

Taking everything into account, LION scores 2 out of 10 in our fundamental rating. LION was compared to 71 industry peers in the Entertainment industry. LION scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LION has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

LION had positive earnings in the past year.
LION Yearly Net Income VS EBIT VS OCF VS FCFLION Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

With a decent Return On Assets value of 2.08%, LION is doing good in the industry, outperforming 72.73% of the companies in the same industry.
LION has a Return On Equity of 2.17%. This is in the better half of the industry: LION outperforms 71.21% of its industry peers.
Industry RankSector Rank
ROA 2.08%
ROE 2.17%
ROIC N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LION Yearly ROA, ROE, ROICLION Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15 -20

1.3 Margins

LION does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LION Yearly Profit, Operating, Gross MarginsLION Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

5

2. Health

2.1 Basic Checks

The number of shares outstanding for LION remains at a similar level compared to 1 year ago.
LION has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LION Yearly Shares OutstandingLION Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
LION Yearly Total Debt VS Total AssetsLION Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

LION has an Altman-Z score of 42.49. This indicates that LION is financially healthy and has little risk of bankruptcy at the moment.
LION has a better Altman-Z score (42.49) than 100.00% of its industry peers.
There is no outstanding debt for LION. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 42.49
ROIC/WACCN/A
WACCN/A
LION Yearly LT Debt VS Equity VS FCFLION Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

LION has a Current Ratio of 0.02. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.02, LION is doing worse than 98.48% of the companies in the same industry.
LION has a Quick Ratio of 0.02. This is a bad value and indicates that LION is not financially healthy enough and could expect problems in meeting its short term obligations.
LION has a Quick ratio of 0.02. This is amonst the worse of the industry: LION underperforms 98.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
LION Yearly Current Assets VS Current LiabilitesLION Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

0

3. Growth

3.1 Past

LION shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.28%.
EPS 1Y (TTM)-27.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -7.03% on average over the next years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-59.25%
EPS Next 3Y47.52%
EPS Next 5Y-7.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LION Yearly Revenue VS EstimatesLION Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
LION Yearly EPS VS EstimatesLION Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

LION is valuated quite expensively with a Price/Earnings ratio of 46.17.
LION's Price/Earnings ratio is a bit cheaper when compared to the industry. LION is cheaper than 68.18% of the companies in the same industry.
LION is valuated expensively when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 46.17
Fwd PE N/A
LION Price Earnings VS Forward Price EarningsLION Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LION Per share dataLION EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A more expensive valuation may be justified as LION's earnings are expected to grow with 47.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-59.25%
EPS Next 3Y47.52%

0

5. Dividend

5.1 Amount

No dividends for LION!.
Industry RankSector Rank
Dividend Yield N/A

LIONSGATE STUDIOS CORP

NASDAQ:LION (2/21/2025, 8:00:02 PM)

After market: 8.31 0 (0%)

8.31

-0.32 (-3.71%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)05-20 2025-05-20
Inst Owners10.48%
Inst Owner Change12.45%
Ins OwnersN/A
Ins Owner Change0%
Market Cap2.40B
Analysts84.44
Price Target10.71 (28.88%)
Short Float %10.91%
Short Ratio9.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 46.17
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.12
P/tB 3.12
EV/EBITDA N/A
EPS(TTM)0.18
EY2.17%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS2.67
TBVpS2.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.08%
ROE 2.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.47%
ROA(5y)N/A
ROE(3y)-6.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z 42.49
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-27.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2Y-59.25%
EPS Next 3Y47.52%
EPS Next 5Y-7.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1401.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y156.67%
EBIT Next 5Y110.23%
FCF growth 1Y0.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.19%
OCF growth 3YN/A
OCF growth 5YN/A